Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain

Exclusion Criteria

• •1. With other peripheral neuropathies or painful diseases except for Diabetic Peripheral Neuropathic Pain;
• •2. Possibly allergic to the active ingredients or excipients of JMKX000623, pregabalin and acetaminophen, or history of ≥ 3 allergens, or with ongoing allergic conditions;
• •3. Received analgesic medications within 4 weeks prior to screening, or scheduled to use other analgesic medications during the trial;
• •4. Known treatment failure on pregabalin or gabapentin;